Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| Chromocell Therapeutics Corp | SC 13G/A | 13 Nov 2024 |
| Oklo Inc | SC 13G/A | 13 Nov 2024 |
| Sutro Biopharma Inc | SC 13G/A | 13 Nov 2024 |
| TXO Partners LP | SC 13G/A | 13 Nov 2024 |
| AN2 Therapeutics Inc | SC 13G/A | 13 Nov 2024 |
| Aimei Health Technology Co Ltd | COWEN AND COMPANY, LLC | 13 Nov 2024 |
| Aimei Health Technology Co Ltd | SC 13G/A | 13 Nov 2024 |
| ADC Therapeutics SA | SC 13G/A | 13 Nov 2024 |
| ADC Therapeutics SA | SC 13G/A | 13 Nov 2024 |
| Patria Latin American Opportunity Acquisition Corp | SC 13G/A | 13 Nov 2024 |
| 4D Molecular Therapeutics Inc | AMENDMENT NO. 3 TO SCHEDULE 13G | 13 Nov 2024 |
| Aaon Inc | SC 13G/A | 13 Nov 2024 |
| SilverBox Corp III | SC 13G/A | 13 Nov 2024 |
| State Street Corp | SC 13G/A | 13 Nov 2024 |
| Charter Communications Inc | SC 13G/A | 13 Nov 2024 |
| Stronghold Digital Mining Inc | SC 13G/A | 13 Nov 2024 |
| Adaptimmune Therapeutics PLC | ADAPTIMMUNE THERAPEUTICS PLC | 13 Nov 2024 |
| Sharkninja Inc | SC 13G/A | 13 Nov 2024 |
| Prothena Corporation PLC | SC 13G/A | 13 Nov 2024 |
| Frontier Group Holdings Inc | SC 13G/A | 13 Nov 2024 |
